Massive Bio AI‑Driven Oncology Platform Partners with GELL to Boost Latin America Clinical Research
Massive Bio and GELL Announce Partnership to Advance AI‑Powered Oncology Research in Latin America and the U.S. The collaboration brings together Massive Bio’s artificial‑intelligence platform for trial matching and patient navigation with the Latin American Study Group on Lymphoproliferative Disorders (GELL), a network of more than 20 countries that shapes lymphoma research and education across…
